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Abstract
Background—In Zambia, a country with a generalized HIV epidemic, age-adjusted cervical
cancer incidence is among the highest worldwide. In 2006, the UAB-Center for Infectious Disease
Research in Zambia and the Zambian Ministry of Health launched a visual inspection with acetic
acid (VIA)-based “see and treat” cervical cancer prevention program in Lusaka. All services were
integrated within existing government-operated primary health care facilities.
Objective—Study aims were to: 1) identify women's motivations for cervical screening; 2)
document women's experiences with screening; and 3) describe the potentially reciprocal
influences between women undergoing cervical screening and their social networks.
Design & Methods—Focus group discussions (FGD) and in-depth interviews (IDI) were
conducted with women who accepted screening and with care providers. Low-level content
analysis was performed to identify themes evoked by participants. Between September, 2009 and
July, 2010, 60 women and 21 care providers participated in 8 FGD and 10 IDI.
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Results—Women presented for screening with varying needs and expectations. A majority
discussed their screening decisions and experiences with members of their social networks. Key
reinforcing factors and obstacles to VIA screening were identified.
Conclusions—Interventions are needed to gain support for the screening process from
influential family members and peers.
Keywords
Zambia; cervical cancer; mass screening; HIV/AIDS; access to care; experience with care; social
network
INTRODUCTION
Invasive cervical cancer (ICC) is the leading cause of cancer-related morbidity and mortality
among women in developing countries 1. A growing body of evidence has demonstrated that
women can be effectively screened and clinically managed for precancerous lesions of the
cervix using direct visualization techniques or human papillomavirus (HPV) DNA testing,
coupled with immediate treatment using cryotherapy 2-6.
The need for effective cervical cancer screening programs is especially urgent in global
regions impacted by high female HIV infection rates such as sub-Saharan Africa. Compared
to HIV-uninfected women, HIV-infected women (on HAART or not) are at higher risk for
chronic infection with oncogenic strains of HPV, for development of cervical intraepithelial
neoplasia (CIN), and for persistence and recurrence of CIN post-treatment7-9. As a result,
once-in-a-lifetime screening strategies are unlikely to substantially reduce ICC risk in HIV-
infected women10. This poses a unique challenge for program developers in Africa, because
it implies that post-treatment follow-up visits and repeated screening are needed to
effectively prevent ICC in HIV-infected women 11, 12.
In Zambia, HIV prevalence among women 15-49 years is 16.1% nationally and 23.1% in the
capital of Lusaka; 13.disproportionately high rates of HPV and CIN have been reported
among HIV-infected women; 14, 15 and age-adjusted ICC incidence rate is 52.8 per 100,000
women 1. In response, a visual inspection with acetic acid (VIA)-based “see and treat”
cervical cancer prevention program was established in 2006, integrating ICC prevention
activities within existing primary health care facilities in Lusaka and, for HIV positive
women, linking them with HIV treatment and prevention services 16.
Most of the literature regarding women's perceptions of and experiences with cervical
cancer screening, has focused on Papanicolaou (Pap) smear testing, Western settings, or
both 17. As other cervical screening modalities are becoming increasingly available to
women in resource-poor settings, it is necessary to update our appreciation of the
psychosocial factors that influence women's screening decisions. Exploratory, qualitative
research allows for documentation of a wide range of representations, opinions, and
preferences considered by women who choose to undergo cervical screening. In studies
conducted among African populations to date, women conveyed limited understanding or
appreciation of disease prevention through existing cervical screening programs or HPV
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vaccine coverage 18-21. This study employed a descriptive inquiry approach to: 1) identify
screening motivations among women recently screened using VIA methodology; 2)
document women's screening experiences; and 3) describe the potential influences of social
networks on women's initial screening decisions and the potential reciprocal influences of




A descriptive design was employed using qualitative research methods, focus group
discussions (FGD) and in-depth interviews (IDI) to elicit detailed perceptions from women
eligible for VIA screening and health care providers affiliated with the cervical screening
program. Descriptive inquiry approaches seek to comprehensively depict a phenomenon of
interest using the direct language of the participants, with low-level interpretation by the
researchers 22. This approach was well suited to provide insights on an under-studied health
issue in a low-income African setting from the perspective of multiple stakeholders (nurses,
peer educators, screen-eligible women).
Study setting
This study was conducted at a Zambian Ministry of Health primary health center in a
densely populated settlement (Kanyama) located on the outskirts of Lusaka 23. Recruitment
of women from a single clinic was primarily based on practical considerations, such as the
availability of clinic rooms to conduct private discussions and interviews as well as
provision of administrative rooms to accommodate our research team
Study sample
Women eligible for the study were local residents 18-49 years of age; able to undergo VIA
cervical screening15; and conversant in either Bemba or Nyanja, the two languages most
commonly spoken in the capital. All women who participated in FGD and IDI had recently
undergone cervical screening. To obtain the opinions of health care personnel, separate FGD
were held with screening nurses and peer educators from several Lusaka screening clinics.
Due to the limited number of health care personnel at a single clinic, screening nurses and
peer educators were invited from VIA screening clinics throughout Lusaka. This also
provided an opportunity for the research team to assess consistency of findings amongst
personnel from several clinics.
VIA screening procedures
A single nurse is responsible for daily clinical management of the cervical screening
program. Volunteer, lay peer educators circulate daily throughout the clinic to provide
educational talks and invite women for screening. Their messages emphasize that: cervical
cancer has an early stage and a late stage; symptoms occur only during the late stage; it is
best for women to be screened before they experience cancer-related symptoms; and ICC
occurs mainly in women who have never been screened. Directly following this session,
women are invited to direct any questions or concerns to the screening nurse who provides
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detailed explanation of screening procedures. Once women provide verbal consent for
screening, they are escorted to a private exam room and undergo VIA screening procedures
according to international accepted standards 24. When immediate treatment by cryotherapy
is contraindicated, women are referred to a gynecology clinic at a local tertiary care center
for further evaluation and management 25.
Focus group discussion procedures
Ethics committees from the University of Alabama at Birmingham (UAB) and the
University of Zambia (UNZA) reviewed and approved the research protocol. Women who
met eligibility criteria were referred by the screening nurse to study team members who
subsequently invited women to participate in the study. Women who agreed to take part in
the FGD were instructed to return to the clinic and were given date/time reminder cards.
Upon their return, women were given information about the study and asked to sign the
informed consent indicating their willingness to participate. Women were grouped according
to their stated language preference. A pair of FGD was conducted for each group of women
(Bemba, Nyanja) in order to compare responses from the initial discussions using member
checking techniques and to further investigate unclear or unresolved topics. Two FGD were
held specifically with HIV positive women, also divided according to language preference.
Each discussion was led by an experienced Zambian female facilitator who asked a series of
pre-scripted, open-ended questions, encouraged balanced group discussions, and probed
respondents. An observer/recorder documented the general atmosphere, group dynamics,
and individuals’ non-verbal cues. Discussions were recorded on a digital recorder with
participants’ permission and were conducted in a private room at the clinic. Each FGD
lasted approximately 1.5 hours.
In-depth interview procedures
Following the completion of FGD, the research team gathered to identify recurrent themes
and compiled a prioritized list of topics to be explored through IDI. Interview questions
were scripted into a semi-structured format and translated into local languages. All women
who participated in the FGD were asked to consider participating in an interview. Women
who agreed to an IDI were given an appointment reminder card to return for the interview.
Upon her return, after obtaining written consent, each woman was escorted to a private room
in the clinic along with an interview moderator and observer/recorder who conducted each
of the interviews. Each interview lasted no more than 2 hours.
Data analysis
Qualitative content analysis was performed using English translations of verbatim
transcripts as the primary dataset. For qualitative descriptive studies, qualitative content
analysis is the method of choice 22. Briefly, this is an iterative process whereby coding
schema are generated from the data themselves, and the role of the researcher is to organize
and summarize the informational contents of the data through formulation of categories,
themes, and patterns 26. Three investigators (2 U.S.-based and 1 Zambian-based)
independently coded and sorted the data using QSR Nvivo 8.0© software. The team then
met (by phone and in person) to reach consensus on a final coding scheme of dominant
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themes. A fourth U.S. investigator was used to adjudicate any disagreements amongst the
research team as to the coding scheme. Internal consistency of findings was checked using
within-method triangulation of FGD and IDI of three groups, e.g., screening nurses, peer
educators, and women invited for screening.
RESULTS
Between September, 2009 and July, 2010, a total of 60 women (20 Bemba speakers, 20
Nyanja speakers, and 20 self-reported HIV+ women) participated in 6 FGD and 10 IDI. A
total of 11 peer educators and 10 screening nurses participated in two separate FGD.
Responses elicited from both groups indicate that women's reasons for screening were
diverse and often prompted by peers and family members. Women clearly described the
aspects of the screening process that they liked and disliked the most. These data also
suggested that most women discuss their screening decisions and experiences with members
of their social networks. Contrary to our preconceived idea, opinions of HIV-infected and
HIV-uninfected women on the topics of interest were similar. This may reflect the fact that
the HIV/AIDS epidemic has affected the life of every woman in Lusaka one way or another.
Initial motivation for screening
Women described four primary motivations for cervical screening: 1) to know their VIA
status; 2) to facilitate or protect future pregnancy; 3) to utilize free reproductive services;
and 4) to seek resolution of an existing health problem (Table 1).
Most women presented for screening to determine whether they had ICC or not. Many
women confirmed that they were motivated by the fact that gynecological services were
provided at no cost, stating that similar services were ‘expensive elsewhere’. When asked,
“Do you think a woman would come for [cervical] screening even if she feels fine?”, our
respondents held the opinion that generally women do not come to the clinic unless
prompted by physical pain or illness.
Nurses stated that some women come solely for free STI treatment (women who are found
with genital infections are provided with standard course of treatment at no charge and
asked to return for screening following resolution of symptoms). A minority of women
explained that people are sometimes ‘suspicious’ of free health services because such
services often carry an attached stigma of being offered for ‘Satanic reasons’.
Contributors to positive experience with the screening process
When asked, “What did you like most about the screening exam?”, comfort and supportive
attitudes of the screening staff were most commonly cited by respondents. Women described
clinic staff as unusually ‘caring’ and ‘hospitable’, offering words of encouragement and
taking time to explain procedures in detail. These statements were supported by direct
observations from the research team.
In Lusaka, ICC is not considered to be a disease which women can discuss openly. Hence,
confidential communication with staff was also highly valued amongst respondents. Nurses,
in particular, were viewed as reliable confidantes with whom women could discuss problems
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related to their ‘private areas’. Respondents credited the support offered by staff members,
both peer educators and nurses, as facilitating their screening experience, especially during
painful or embarrassing parts of the exam (Table 2, Quotes 1-3).
Women positively described the experience and excitement of viewing images of their
cervix on a screen, perceived to be both a technological novelty and an informative tool to
enhance their understanding of clinical findings (Table 2, Quotes 4-6). Providers agreed that
women were motivated by viewing pictures of their cervix; they also indicated, however,
that in a few cases women found with extensive lesions were upset by the images. Several
women also said they enjoyed the feeling of vinegar being applied to their cervix, describing
this process as ‘cleaning the mouth of the womb’ (Table 2, Quote 9). Nurses confirmed that
women reported that they enjoyed this aspect of the exam. One nurse offered an explanation:
‘Maybe it even feels dry because vinegar is a bit acidic, so somehow it gives one a kind of
sensation like constricting, so maybe [women] like that feeling’. Finally, women appreciated
that the screening exam was performed quickly (Table 2, Quote 10). In other outpatient
clinics women typically wait for several hours before being seen by clinic staff.
Directly following the exam, women commonly remarked that they were relieved to know
their screening status. (Table 2, Quotes 7-8). However, while the majority of women
associated positive feelings of relief with being told that they were free of cervical
abnormalities, others expressed a sense of frustration because they had come seeking
resolution of an ongoing health problem. This scenario is described by a nurse: “When you
say she is negative she will still insist to say, ‘What is this that I am feeling because I
thought that when I come here I would be found with something.” In this sense, cervical
screening seemed to be viewed as a last resort for a minority of women with unresolved
health concerns.
Contributors to negative experience with the screening process
When asked “Which aspects of the screening exam did you like the least?”, respondents
cited three categories of negative experiences: 1) having to undress for the exam; 2) fear of
pain caused by the vaginal speculum, referred to as a chishimbi or ‘steel rod’; and 3) belief
that they could contract diseases, e.g., HIV, from the screening instruments.
Women objected to undressing both for cultural and pragmatic reasons. Zambian cultural
norms do not permit women to be seen nude by anyone but her husband, unless during
childbirth (Table 3, Quote 1). Nurses stated that women unaware of having to undress for
screening refused on the grounds that they needed to bathe before doing so (Table 3, Quote
2).
The most commonly cited negative aspect of screening was women's fear of the vaginal
speculum or “chishimbi”. Women were afraid of the pain when the speculum was inserted
during the pelvic exam, based on stories heard within the community (Table 3, Quotes 3 and
6). Following the exam, women often stated that the pain of the speculum described by other
women in the community was grossly exaggerated: ‘Some say that the chishimbi used in the
exam pains. This is a lie’. Other reasons given for why women were afraid of the speculum
were associated with a minority of women who believed the speculum was used to both
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remove and re-insert the cervix after it had been cleaned by a nurse (Table 3, Quote 4).
Finally, nurses stated that they were forced to spend considerable time explaining to women
how instruments are sterilized daily.
The respondents offered additional concerns not directly related to the screening exam itself;
these included a fear of testing for HIV and cancer-related stigma. (Table 3, Quotes 9-10).
Women stated that ICC is perceived to be closely associated with HIV/AIDS in the
community, so women were hesitant to present for cervical screening for fear of being tested
for HIV (Table 3, Quote 9). Similarly, women did not want to be seen at a ‘cancer clinic’
because, as some suggested, ‘...people think when you come for screening then you are HIV
positive’. Others believed that stigma would be directly related to cancer itself: ‘when
[others] just see you at the cancer clinic they start saying, ‘we saw her at the cancer clinic’
and they start stigmatizing you’. Finally, women perceived that the clinic was understaffed
(Table 3, Quote 11). Each of these barriers was considered serious enough to discourage
some women to attend screening.
Interpersonal communication regarding cervical cancer
We enquired about social norms regarding interpersonal communication on ICC. When
asked, “Do women in your community feel comfortable discussing ICC?” respondents
uniformly replied “no”, because the disease occurs in ‘private areas’ of the body. The
disease has, until recently, been extremely stigmatized in the general population: ‘Before
everybody was scared even when you have relatives who have cervical cancer, it was just
like someone who has HIV.’ When asked to whom, if anyone, a woman might confide if she
felt that she may have this disease, women said that husbands, other family members,
friends, clinic staff, and members of the church could be considered as potential confidantes.
Friends were the most commonly described confidantes, though women had mixed views as
to whether their friends could be trusted with personal information: ‘With us women when
we quarrel, we even talk about confidential information, and thus most women hesitate to
tell their friends’. Because of fears of gossip among friends, clinic staff members were
viewed as confidential resources for women. Women stated that the most important quality
in a potential confidante is that they be trustworthy.
Influence of peers on decision to undergo screening
Women were asked whether they were influenced by others concerning their decision to
undergo screening. Not surprisingly, coming from women who had made the decision to be
screened, most participants indicated having been encouraged rather than discouraged by
members of their social networks, most often close friends and husbands (Table 4, Quotes
1-3). Seeking approval or permission for screening from a spouse was a source of debate
among our respondents. Some women described the need to seek permission as
precautionary, e.g., in the event of screening positive and needing treatment: ‘After the
screening, if you are found with the lesion and you are treated, your husband will understand
if he gave you permission’. Others felt that approval from their husbands was a means of
garnering emotional support.
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A premise of this study is that women who undergo screening might share their positive and
negative screening experiences, thereby influencing other women's decision to undergo
cervical screening. Our results indicated both a positive and negative influence on peers. On
the positive side, several women who underwent screening described a sense of
responsibility to act as screening role models; that is, to impart their experience to other
women in the community, to convey the benefits of screening, and to dispel rumors related
to the screening process. Care providers confirmed that women who had undergone
screening were likely to encourage others because they had “become knowledgeable” about
the process (Table 4, Quotes 4-5). On the negative side, both providers and women felt that
stories of women's negative screening experiences were widespread in the community.
Participants also believed that these stories and related rumors were likely to impact
community perceptions of cervical screening negatively and thereby deter some women to
come for cervical screening (Table 4, Quotes 6-8).
DISCUSSION
The present study sought to clarify relations among motivations for cervical screening,
screening experiences, and social influences on the decision for cervical screening among
women who accepted to undergo a VIA exam at a peri-urban primary health center in
Lusaka, Zambia. Our results indicate that women presented for screening with variable
needs and expectations, often prompted by friends and family members. Women articulated
a wide range of screening experiences and reported often discussing these experiences, both
positive and negative, with others in the community.
Most study participants sought cervical screening to find out their VIA status. In line with
the core educational message of the program, some women explicitly stated that the disease
can exist in the absence of symptoms. Conversely, though, and as in other African
studies, 17-19 participants suggested that some women may be reluctant to come to the clinic
if not prompted by physical symptoms of illness. If widespread, this attitude could reduce
the effectiveness of the screening program.
Women were motivated to present for screening by factors other than cervical disease itself.
Some women wanted to be reassured of their reproductive health and their ability to bear
children. Loss of fertility as grounds for divorce has been cited as a major concern among
African women 21. Based on our results, addressing fertility-related concerns is a priority
among women and could be an entrée into emphasizing the importance of general cervical
health and the role of cervical screening. Finally, a minority of women sought diagnosis for
unresolved symptoms and became frustrated when told that they were screen-negative. By
presenting with health problems beyond the scope of the program, these women may
develop misaligned perceptions of program utility and effectiveness.
Our study sought to document women's experiences with the screening process. Women in
this population had extremely positive perceptions of health providers associated with the
screening program. Lay peer educators, who have proven to be successful in increasing
cervical screening uptake among minority U.S. populations, were viewed as informative and
supportive prior to screening 27. Nurses were seen as professional confidantes with whom
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women could express their health concerns freely in a private setting. These experiences
contrast sharply with other African studies in which women felt intimidated, rushed, or
unwelcomed by care providers 28, 29. Trust in care providers has been cited as one of the
crucial factors in a woman's decision to undergo cervical screening 30. Our data suggest that
successful measures were taken in Lusaka to engaging with women throughout the
screening process and, thus, ensure that they have a positive experience of care.
In relation to the actual exam, women conveyed both positive and negative opinions. Having
the opportunity to see one's cervix was a clear motivating factor among respondents. Care
providers viewed digital cervicography as a useful education tool, while women appreciated
the novelty of viewing these images. Given the additional practical benefit of using
enhanced images for quality control and diagnostic purposes, 31, 32 cervicography may be a
feature of cervical screening to be emphasized in future screening promotion messages. Both
screening participants and nurses stated that women seemed to enjoy the application of
vinegar to the cervix, likely due to its acidity and because it seemed to impart of feeling of
‘constriction’ and ‘cleanliness’ among women. This preference may reflect a cultural
predilection for vaginal astringent products used in dry sex practices among Zambian
populations. 33
Negative aspects of the screening exam included women's discomfort from having their
genitals exposed during the exam, viewed as a cultural taboo among our respondents and
cited elsewhere as a barrier to cervical screening 34-36. Women objected to the use of the
vaginal speculum for fear of pain and a belief that it was used to remove and clean the
cervix 19. Also, women associated the speculum with potential transmission of STIs,
including HIV, a significant concern for screening participants in a country with high HIV
disease prevalence.
Our data indicate that women communicate their screening experiences with others, possibly
influencing community perceptions of need for screening both positively and negatively.
Although many women, after being screened, appear to become role models for other
women in their social networks, some women disseminate messages that may reinforce
‘attitudinal barriers’37. Because only women who evaluate their experience positively are
likely to become natural helpers, it is crucial to monitor women's experiences with the
screening process and address any area of concern.
Women's responses indicated that the decision to undergo screening was influenced by
social networks. A proportion of women sought their husband's explicit permission for
cervical screening, signaling a need to create screening promotion messages and cervical
educational materials targeted to women's partners. While few attempts have been made yet
to formally influence or include a women's family into cervical screening promotion efforts
in Zambia, individual screening programs should determine the suitability and impact of
communication messages to educate influential individuals regarding the risks and benefits
of cervical screening and treatment.
When assessing the significance of our results, one should keep in mind that information
consisted primarily of self-reports obtained from a convenient sample of women who
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presented at one screening clinic. These women may have had more positive views of
cervical screening than members of the general community. Furthermore, VIA testing is
offered in fifteen government clinics in various neighborhoods of Lusaka; we cannot
exclude that women recruited from other clinics than Kanyama might have reported
different motivations and experiences. To offset these limitations, however, and obtain a
broader view of the cervical screening program we interviewed care providers representing a
total of ten screening clinics.
CONCLUSION
Confidential communication and support of care providers are as crucial to the success of
cervical cancer screening programs in resource-limited settings as they are in resource-rich
settings; they might also be a prerequisite of effective retention of HIV-infected women into
preventive care. Cervical screening professionals should carefully account for women's
motivations and fears when articulating the objectives and limitations of cervical cancer
screening. Misalignments between women's expectations and program goals and procedures
may result in negative experiences, drop outs, and bad press for the program in the
community. Further research is needed to understand the role played by family members and
peers into women's decisions to present for initial screening and subsequent care, as
indicated.
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Current knowledge on this subject
Once-in-a-lifetime “screen and treat” protocols based on low-technology visualization
techniques, or human papillomavirus DNA testing, can effectively reduce global rates of
invasive cervical cancer among women in resource-limited countries.
Special challenges are encountered in regions with generalized HIV epidemic such as
sub-Saharan Africa, because post-treatment follow-up visits and repeated screening are
needed to effectively prevent cervical cancer in HIV-infected women.
In resource-rich countries, cervical cancer screening causes embarrassment, fear,
discomfort and inconvenience that act as deterrent in many women.
What this study adds
Women who attended a cervical cancer prevention program in Lusaka, Zambia, cited
trust in screening personnel as the most important determinant of a positive screening
experience.
In the context of screening by visualization of the cervix, being offered the possibility to
see a digital picture of one's cervix, along with receiving brief explanations from the
screening nurse, was a strong motivator for many women.
Most Zambian women discuss their screening decisions with members of their social
networks before attending screening. After screening, women who had mainly positive
screening experiences tend to promote screening in their networks, whereas women who
had mixed experiences are more likely to exert a negative influence on their peers.
White et al. Page 13











































White et al. Page 14
Table 1
Quotes from focus group discussions and interviews with providers and women on initial motivation for
cervical cancer screening.
Number Quote Theme Respondent
1. Women want to know if they have cervical cancer. Know VIA status Woman
2. You will be able to know if you have the lesions that cause cancer or not. Know VIA status Woman
3. I came for tests because I want to have children. Protect future pregnancy Woman
4. It made me happy with the help they gave. It was absolutely free. Free services Woman
5. They will come because they have an STI and feel we are the right people
who will not disclose to other people.
Resolution of existing health
problem (genital symptoms)
Nurse
6. I wanted to know the reason why my health was deteriorating. Resolution of existing health
problem
Woman
7. When one is sick and does not know what is wrong with her, [she] is
hoping they tell her she has cancer, and that's why she is sick.
Resolution of existing health
problem
Woman
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Table 2
Quotes from focus group discussions and interviews with care providers and women on positive contributors
to the cervical screening experience.
Number Quote Theme Respondent
1. We feel free and comfortable when we come here, and this encourages us a lot. Comfort from providers Woman
2. They feel more comfortable to talk to us because they know that whatever we do
is confidential.
Confidentiality of exam Nurse
3. When the nurse told me I was found with a problem I was afraid, but the nurse
calmed me and encouraged me.
Encouragement of providers Woman
4. I loved it when I was shown the picture of my womb and how it is. Digital cervicography Woman
5. The fact that they can see their cervix which they have never seen really excites
women.
Digital cervicography Nurse
6. The nurse showed me how my womb was. I was happy because I know the
problem I have.
Digital cervicography Woman
7. Knowing my [screening] results. You are relieved once you know. Relief of screening result Woman
8. Also me, [after] knowing my results I was happy. Relief of screening result Woman
9. [Women] know that the vinegar applied on their cervix helps to clean it. Effects of vinegar Woman
10. At Kanyama clinic, they do not take too much time to do their work. Screening performed quickly Woman
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Table 3
Quotes from focus group discussions and interviews with care providers and women on negative contributors
to the screening experience.
Number Quote Theme Respondent
1. It is not acceptable for someone to see your vagina except for when you're
giving birth.
Undressing Woman
2. Some say they need a bath before being examined. They think they are not
clean enough to open their private parts.
Undressing Nurse
3. [Women] do not want pieces of metal inserted in the vagina. Fear of speculum/pain Peer educator
4. The uterus is pulled out cleaned and treated and put back inside. Fear of speculum/procedure Woman
5. Even just hearing the sound of the instrument [a woman] will jump. Fear of speculum/procedure Nurse
6. The chisimbi (steel rod) when inserting in the vagina pains. Fear of speculum/pain Woman
7. People say they use the same instruments on all women. Fear of infection from instruments Woman
8. The object that they push into the vagina, it brings other infections if it's
not well cleaned.
Fear of infection from instruments Woman
9. Other women in the community they do not know that they screen for
cancer here, they think that they only do HIV test.
Fear of HIV testing Woman
10. [Women] don't want to be seen at the cancer clinic. They want it to be a
secret.
Stigma Peer Educator
11. There is only one nurse to do the screening, there are times when she is not
there.
Understaffing Woman
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Table 4
Quotes from focus group discussions and interviews with care providers and women regarding influence of
social network on the decision to undergo screening.
Number Quote Theme Respondent
1. For me, I was constantly ill so my friends encouraged me to come
for screening.
Encouragement from friends Woman
2. Most [women] are coming because they have a complaint which
they told a friend and the friend told them to try the cervical cancer
clinic.
Encouragement from friends Nurses
3. I took the [screening] pamphlet to my husband, and he told me to
come for screening.
Encouragement from husbands Woman
4. I was motivated [after screening], and I wanted to encourage my
friends as an example.
Positive influence of others' screening
experiences
Nurse
5. It is important for us women to encourage one another to come for
screening.
Positive influence of others'screening
experiences
Woman
6. Patients tell their friends that the steel [speculum] is very big and is
put as if it can kill a person.
Negative influence of others'screening
experiences
Woman
7. Most women are scared to come because of the stories they hear
from those who have been here before. They are very discouraging.
Negative influence of others'screening
experiences
Peer Educator
8. To be honest, there is so much that has been said in our compounds
with regard to screening. It puts so much fear in most of us that you
think twice before coming.
Negative influence of others'screening
experiences
Woman
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